Literature DB >> 25427653

11C-methionine PET/CT after inconclusive 99mTc-MIBI-SPECT/CT for localisation of parathyroid adenomas in primary hyperparathyroidism.

U Braeuning, C Pfannenberg, B Gallwitz, R Teichmann, M Mueller, H Dittmann, M Reimold, R Bares1.   

Abstract

AIM: To investigate the efficacy of PET/CT with 11C-methionine for localizing parathyroid adenomas in patients with suspected primary hyperparathyroidism and inconclusive results of cervical ultrasonography and 99mTc-MIBI-SPECT/CT. PATIENTS,
METHOD: Retrospective analysis of imaging data of 18 patients and correlation with clinical outcome, in particular intraoperative findings and histopathology of excised tissue.
RESULTS: 12 of 18 patients received surgery. In 10 patients single parathyroid adenomas were found (diameter: 5-20 mm), 2 patients presented parathyroid hyperplasia (5 excised hyperplastic glands (diameter: 2-12 mm). PET/CT correctly localized all adenomas and 1 of 5 hyperplastic glands. The sensitivity per patient was 91.7% (11 of 12), the sensitivity per lesion 73.3% (11 of 15). All lesions missed by PET/CT had a size smaller than 9 mm and a volume of less than 0.2 ml. In 6 patients no surgery was performed. Five of them had a negative or atypical PET/CT. Further follow-up indicated familial hypocalciuric hypercalcemia in 3 of them (thus, PET/CT true negative), in the remaining 2 patients no validation is available. One patient with 2 highly suggestive lesions rejected surgery so far.
CONCLUSION: PET/CT with 11C-methionine is a very sensitive method for the detection of parathyroid adenomas, even if they are too small to be visualized by 99mTc-MIBI-SPECT/CT.

Entities:  

Keywords:  11C-methionine-PET/CT; 99mTc-MIBI-SPECT/CT; primary hyperparathyreoidism

Mesh:

Substances:

Year:  2014        PMID: 25427653     DOI: 10.3413/Nukmed-0686-14-07

Source DB:  PubMed          Journal:  Nuklearmedizin        ISSN: 0029-5566            Impact factor:   1.379


  6 in total

1.  PRIMARY HYPERPARATHYROIDISM - STRATEGY FOR MULTIGLAND DISEASE IN THE ERA OF SPECT-CT.

Authors:  I T Cvasciuc; W Ismail; M Lansdown
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Jan-Mar       Impact factor: 0.877

Review 2.  Use of PET tracers for parathyroid localization: a systematic review and meta-analysis.

Authors:  Wouter P Kluijfhout; Jesse D Pasternak; Frederick Thurston Drake; Toni Beninato; Jessica E Gosnell; Wen T Shen; Quan-Yang Duh; Isabel E Allen; Menno R Vriens; Bart de Keizer; Miguel H Pampaloni; Insoo Suh
Journal:  Langenbecks Arch Surg       Date:  2016-04-16       Impact factor: 3.445

3.  Localization of parathyroid adenomas using 11C-methionine pet after prior inconclusive imaging.

Authors:  Milou E Noltes; Annemieke M Coester; Anouk N A van der Horst-Schrivers; Bart Dorgelo; Liesbeth Jansen; Walter Noordzij; Clara Lemstra; Adrienne H Brouwers; Schelto Kruijff
Journal:  Langenbecks Arch Surg       Date:  2017-01-14       Impact factor: 3.445

4.  Can Met-PET/CT Predict Sporadic Multiglandular Hyperparathyroidism? Report of a Case and Review of the Literature.

Authors:  Andreas Hillenbrand; Johannes Lemke; Doris Henne-Bruns; Ambros J Beer; Vikas Prasad
Journal:  Case Rep Endocrinol       Date:  2019-05-15

5.  A Woman with a 27-Year History of Hyperparathyroidism and Hypercalcemia Who Was Diagnosed with Low-Grade Parathyroid Carcinoma.

Authors:  Monika Kaszczewska; Michał Popow; Witold Chudziński; Joanna Kaszczewska; Magdalena Bogdańska; Joanna Podgórska; Agnieszka Czarniecka; Zbigniew Gałązka
Journal:  Am J Case Rep       Date:  2021-03-11

6.  Role of 11C-Methionine PET/CT in 99mTc-Sestamibi-Negative Parathyroid Adenoma: A Case Report.

Authors:  Jang Yoo; Miju Cheon
Journal:  Diagnostics (Basel)       Date:  2021-05-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.